Hepatology

Several presentations at the recent International Liver Congress™ (ILC), held in London, UK, from 22nd–26th of June 2022, addressed the role of the gut microbiome in chronic liver disease.

PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.

There is growing recognition of acute-on-chronic liver failure (ACLF) as a distinct clinical syndrome that portends excessively high…

Non-alcoholic steatohepatitis (NASH) is the potentially progressive form of non-alcoholic fatty liver disease (NAFLD). NAFLD and NASH are very common in most regions of the world and are on trajectory to become the most common liver disease at a global scale. Risk for high prevalence and progressiveness include visceral obesity and Type 2 diabetes.

A 73-year-old female presented with a rare presentation of extrahepatic ductal injuries post-trauma in the form of a right hepatic duct injury. Such injuries go undetected despite normally advised imaging, presenting a few to several days post-trauma.

Cholestatic liver diseases are the leading indications for paediatric liver transplant, and result in significant morbidity and mortality.

I have always been curious, wanting to understand how and why everything works. My interest in biology began in secondary school in Ireland, where I had a very energetic teacher, Mr Whisker.

I guess it was a combination of different things. Firstly, hepatology is a very wide specialty that combines internal medicine with interventional procedures, and I liked that very much; secondly, I had an excellent group of medical school teachers who instilled in me their passion for the liver and encouraged me to choose the specialty.